Look For The Q4 Biotech Bounce In Mid-Small Caps
September 17, 2021 at 00:00 AM EDT
Large-cap biopharma stocks are off their highs because of prospects that drug prices may be directly negotiated through Medicare but several Democrats are not in agreement as to how this could be best accomplished.
